1. Home
  2. WASH vs EYPT Comparison

WASH vs EYPT Comparison

Compare WASH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WASH
  • EYPT
  • Stock Information
  • Founded
  • WASH 1800
  • EYPT 1987
  • Country
  • WASH United States
  • EYPT United States
  • Employees
  • WASH N/A
  • EYPT N/A
  • Industry
  • WASH Major Banks
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • WASH Finance
  • EYPT Industrials
  • Exchange
  • WASH Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • WASH 542.9M
  • EYPT 579.4M
  • IPO Year
  • WASH N/A
  • EYPT 2005
  • Fundamental
  • Price
  • WASH $28.72
  • EYPT $9.55
  • Analyst Decision
  • WASH Buy
  • EYPT Strong Buy
  • Analyst Count
  • WASH 4
  • EYPT 8
  • Target Price
  • WASH $32.25
  • EYPT $24.75
  • AVG Volume (30 Days)
  • WASH 148.4K
  • EYPT 841.7K
  • Earning Date
  • WASH 07-21-2025
  • EYPT 08-06-2025
  • Dividend Yield
  • WASH 7.92%
  • EYPT N/A
  • EPS Growth
  • WASH N/A
  • EYPT N/A
  • EPS
  • WASH N/A
  • EYPT N/A
  • Revenue
  • WASH $110,088,000.00
  • EYPT $56,042,000.00
  • Revenue This Year
  • WASH $57.46
  • EYPT N/A
  • Revenue Next Year
  • WASH $9.82
  • EYPT N/A
  • P/E Ratio
  • WASH N/A
  • EYPT N/A
  • Revenue Growth
  • WASH N/A
  • EYPT 12.04
  • 52 Week Low
  • WASH $24.95
  • EYPT $3.91
  • 52 Week High
  • WASH $40.59
  • EYPT $13.99
  • Technical
  • Relative Strength Index (RSI)
  • WASH 59.78
  • EYPT 61.03
  • Support Level
  • WASH $27.48
  • EYPT $7.94
  • Resistance Level
  • WASH $28.25
  • EYPT $10.77
  • Average True Range (ATR)
  • WASH 0.66
  • EYPT 0.76
  • MACD
  • WASH 0.18
  • EYPT -0.01
  • Stochastic Oscillator
  • WASH 85.12
  • EYPT 56.89

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: